Richard Barager
Nephrology · Oceanside, CANPI 1508864448
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $769 and has fallen 90.7% since, to $72 in 2023.
Across 78 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$221
- OPKO Pharmaceuticals, LLC$208
- AstraZeneca$173
- Otsuka America Pharmaceutical, Inc.$170
- Amgen$156
- Akebia Therapeutics Inc$146
- plus $490 from 13 others
What the payments were for
- Food & beverage$1,562100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 11 | $221 |
| OPKO Pharmaceuticals, LLC | 11 | $208 |
| AstraZeneca | 9 | $173 |
| Otsuka America Pharmaceutical, Inc. | 9 | $170 |
| Amgen(2 entities) | 7 | $156 |
| Akebia Therapeutics Inc | 8 | $146 |
| Fresenius USA Marketing, Inc. | 6 | $108 |
| Bayer | 4 | $78 |
| Outset Medical Inc | 1 | $72 |
| Mallinckrodt Enterprises LLC | 2 | $53 |
| GSK | 2 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
| Novo Nordisk | 1 | $12 |
How this compares
$1,565 in reported general payments places this provider in the 55th percentile of 1,341 nephrology providers in California.
Other nephrology in Oceanside
- Anjay RastogiLos Angeles$2.2M
- Glenn ChertowStanford$2M
- Luis AlvarezPalo Alto$1.8M
- Jose MorfinSacramento$1M
- Rodolfo BatarseRancho Mirage$910K
- Vandana MathurWoodside$769K
- Yasir QaziOrange$618K
- Rafael VillicanaLoma Linda$610K
- Sunil PatelApple Valley$509K
- Suphamai BunnapradistLos Angeles$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.